Goldhaber S Z
Harvard Medical School, Boston, Massachusetts, USA.
Clin Chest Med. 1995 Jun;16(2):307-20.
Thrombolytic therapy for venous thromboembolism is returning, especially for the management of acute pulmonary embolism patients who present with either hypotension or with right ventricular dysfunction despite an initially normal blood pressure and heart rate. Clinicians have learned to use thrombolysis to improve efficacy, minimize bleeding complications, and achieve savings in cost. The objective of therapy is rapid reversal of right ventricular dysfunction, which might otherwise lead to intractable right ventricular failure and death.
静脉血栓栓塞症的溶栓治疗正在回归，尤其是用于治疗急性肺栓塞患者，这些患者要么出现低血压，要么尽管初始血压和心率正常，但存在右心室功能障碍。临床医生已学会使用溶栓疗法来提高疗效、将出血并发症降至最低并节省成本。治疗的目标是迅速逆转右心室功能障碍，否则可能会导致难治性右心室衰竭和死亡。
